Felix van Lier

Felix van Lier is a Researcher in the Department of Anesthesiology at Erasmus MC, a leading academic medical center in the Netherlands. His work is centered on improving perioperative outcomes, particularly in patients undergoing noncardiac and vascular surgeries. He is actively involved in clinical research focusing on abdominal aortic aneurysm management, hypotension, myocardial infarction, and biomarker discovery.

His research interests span anesthesiology, perioperative medicine, vascular surgery, and clinical epidemiology. He employs advanced methodologies including systematic reviews, meta-analyses, and randomized controlled trials to evaluate patient outcomes. A significant portion of his work investigates the use of multi-omics to identify biomarkers predictive of aneurysm growth and surgical risk.

The recent trends in his publications highlight a strong focus on patient-centered outcomes such as quality of life, anxiety, and depression in vascular patients. His studies often involve large collaborative teams and are published in high-impact journals like Journal of Vascular Surgery, European Journal of Anaesthesiology, and Atherosclerosis.

Felix van Lier has contributed to multiple scientific publications, with a particular emphasis on evidence synthesis and translational research. While no formal awards or fellowships are listed, his work is cited in academic and social platforms including Scopus, Mendeley, and X (formerly Twitter).

He is engaged in advising and collaborative research, frequently co-authoring with senior investigators in anesthesiology and vascular surgery. Though no direct mentorship of students is documented, his involvement in doctoral theses and multi-center studies suggests a role in guiding junior researchers. His work is supported by institutional and possibly national research frameworks, given the scale of the trials he participates in.

Felix van Lier is part of a robust research network at Erasmus MC, collaborating across disciplines in anesthesiology, cardiology, and vascular surgery. His team utilizes advanced imaging, biomarker analysis, and clinical data to improve perioperative care and long-term outcomes for high-risk surgical patients.